September 29, 2021
Kayoko Saito, Professor, Tokyo Women’s Medical University (Courtesy of Chugai Pharmaceutical) Chugai Pharmaceutical’s oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam) will provide a new treatment option for SMA patients who have developed scoliosis, Kayoko Saito, professor at Tokyo Women’s...read more